ALL
Clinical trials for ALL explained in plain language.
Never miss a new study
Get alerted when new ALL trials appear
Sign up with your email to follow new studies for ALL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for hard-to-treat leukemia
Disease control OngoingThis early-phase study tests whether combining two drugs, venetoclax and inotuzumab ozogamicin, is safe and effective for people with B-cell acute lymphoblastic leukemia (B-ALL). About 23 adults with CD22-positive B-ALL that has come back or not responded to treatment will receiv…
Matched conditions: ALL
Phase: PHASE1 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New light treatment aims to clear brain fog in cancer survivors
Symptom relief OngoingThis study tests a new approach to help childhood cancer survivors who struggle with memory, attention, and thinking after their treatment. Participants use a special light device at home while doing brain-training exercises. The goal is to see if this is practical and if it can …
Matched conditions: ALL
Phase: NA • Sponsor: St. Jude Children's Research Hospital • Aim: Symptom relief
Last updated May 17, 2026 05:31 UTC